Canada markets closed

PFE Jan 2024 57.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
8.85+0.45 (+5.36%)
As of 12:02PM EST. Market open.
Full screen
Previous Close8.40
Open8.90
Bid8.55
Ask8.85
Strike57.50
Expire Date2024-01-19
Day's Range8.85 - 8.90
Contract RangeN/A
Volume35
Open Interest564
  • Reuters

    UPDATE 1-Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

    Pfizer Inc and its German partner BioNTech SE fired back at Moderna Inc with counterclaims in a patent lawsuit in Boston federal court on Monday over their rival COVID-19 vaccines, seeking dismissal of the lawsuit and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany.

  • Reuters

    Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

    Pfizer Inc and its German partner BioNTech SE fired back at Moderna Inc with counterclaims in a patent lawsuit in Boston federal court on Monday over their rival COVID-19 vaccines, seeking dismissal of the lawsuit and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany.

  • Reuters

    UPDATE 1-Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5

    Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years. If authorized, children would receive the primary series consisting of two doses of the original Pfizer-BioNTech COVID vaccine and one shot of the Omicron-adapted bivalent vaccine, the company said. The bivalent COVID-19 vaccine, which targets the original strain and the BA.4/BA.5 Omicron subvariants, is currently authorized as a booster dose for ages 5 years and older in the United States and the European Union (EU).